IP Library Granted Patent US 9,551,003
Granted Patent B2
US 9,551,003 · App. 11/520,036 · Granted Jan 24, 2017

Increasing levels of nicotinic alkaloids in plants

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,551,003
App. No.
11/520,036
Granted
Jan 24, 2017
Kind
B2
Abstract

Four genes, A622, NBB1, PMT, and QPT, can be influenced for increasing nicotinic alkaloid levels in Nicotiana plants, as well as for synthesizing nicotinic alkaloids in non-nicotine producing plants and cells. In particular, overexpressing one or more of A622, NBB1, PMT, and QPT may be used to increase nicotine and nicotinic alkaloid levels in tobacco plants. Non-nicotine producing cells can be engineered to produce nicotine and related compounds by overexpressing A622 and NBB1.

Claims (20)

1. A method for increasing nicotine in a Nicotiana plant relative to a control plant, said method comprising genetically engineering overexpression in said Nicotiana plant of:

(a) SEQ ID NO: 1 or SEQ ID NO: 2, and

(b) SEQ ID NO: 3 or SEQ ID NO: 4.

2. The method of claim 1 , wherein SEQ ID NO: 1 is overexpressed.

3. The method of claim 1 , wherein SEQ ID NO: 3 is overexpressed.

4. The method of claim 1 , wherein SEQ ID NO: 1 and SEQ ID NO: 3 are overexpressed.

5. The method of claim 4 , further comprising overexpressing at least one of quinolate phosphoribosyl transferase and putrescine methyl transferase.

6. The method of claim 1 , wherein quinolate phosphoribosyl transferase, putrescine methyl transferase, and the polypeptide having the amino acid sequence set forth in SEQ ID NO: 2 are overexpressed.

7. An increased nicotine plant produced by any one of the methods of claims 1 - 5 , said plant having an increased nicotine content relative to a non-genetically engineered control plant.

8. A nicotine product produced from the increased nicotine plant of claim 7 .

9. The product of claim 8 , wherein said product is selected from the group consisting of a cigarette, a pharmaceutical, and a nutraceutical.

10. A method for increasing nicotine in a Nicotiana plant relative to a control plant, said method comprising genetically engineering overexpression in said Nicotiana plant of at least one of:

(a) SEQ ID NO: 1; or

(b) SEQ ID NO: 2.

11. The method of claim 10 , wherein SEQ ID NO: 1 is overexpressed.

12. The method of claim 10 , wherein a polypeptide having the amino acid sequence set forth in SEQ ID NO: 4 and the polypeptide having the amino acid sequence set forth in SEQ ID NO: 2 are overexpressed.

13. The method of claim 12 , further comprising overexpressing at least one of quinolate phosphoribosyl transferase and putrescine methyl transferase.

14. The method of claim 13 , wherein quinolate phosphoribosyl transferase, a polypeptide having the amino acid sequence set forth in SEQ ID NO: 4, and the polypeptide having the amino acid sequence set forth in SEQ ID NO: 2 are overexpressed.

15. An increased nicotine plant produced by any one of the methods of claims 10 - 14 , said plant having an increased nicotine content relative to a non-genetically engineered control plant.

16. A nicotine product produced from the increased nicotine plant of claim 15 .

Assignments (2)
PATENT SECURITY AGREEMENT Recorded Mar 29, 2023
From: 22ND CENTURY GROUP, INC.
To: JGB COLLATERAL, LLC
Reel/Frame 063188/0812 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2010
From: NARA INSTITUTE OF SCIENCE AND TECHNOLOGY
To: 22ND CENTURY LIMITED, LLC
Reel/Frame 024255/0031 →